Skip to main content
Philogen logo

Philogen — Investor Relations & Filings

Ticker · PHIL ISIN · IT0005373789 LEI · 81560009EA1577917768 XMIL Manufacturing
Open in API
Filings indexed 377 across all filing types
Latest filing 2022-08-02 Director's Dealing
Country IT Italy
Listing XMIL PHIL

About Philogen

https://www.philogen.com

Philogen is a clinical-stage biotechnology company focused on the discovery and development of novel biopharmaceutical products for the treatment of cancer and other serious conditions associated with angiogenesis. Founded in 1996, the company's core strategy is based on innovating targeted therapies, such as antibody-cytokine fusions, which are designed to selectively deliver therapeutic agents to the site of disease. This approach aims to increase efficacy while reducing toxicity. Philogen operates as an integrated company with capabilities in research, GMP manufacturing, and clinical development of its proprietary product pipeline.

Recent filings

Filing Released Lang Actions
Allegato 3F
Director's Dealing Classification · 99% confidence The document is titled "SCHEMA DI COMUNICAZIONE DELLE OPERAZIONI SUI TITOLI DELL'EMITTENTE" (MODEL DISCLOSURE FOR TRANSACTIONS IN THE ISSUER'S SECURITIES). It details specific transactions (Quantità/Quantity, Prezzo/Price) involving the issuer's shares (AZIONE) by the issuer itself (PHILOGEN S.p.A.) during July 2022. This structure perfectly matches the definition of a report detailing the company buying back or selling its own shares, which corresponds to the 'Transaction in Own Shares' category. The filing type code for Transaction in Own Shares is POS.
2022-08-02 Italian
Comunicato Stampa settimanale acquisto azioni proprie
Transaction in Own Shares Classification · 99% confidence The document is titled "AGGIORNAMENTO SUL PROGRAMMA DI ACQUISTO DI AZIONI PROPRIE" (Update on the Share Buyback Program) and details the number of own shares purchased by Philogen S.p.A. during a specific period (July 25, 2022, to July 29, 2022), including daily transaction tables and total figures. This activity—the company buying back its own shares—directly corresponds to the definition of 'Transaction in Own Shares'. The code for this is POS.
2022-08-01 Italian
Comunicato Stampa settimanale acquisto azioni proprie
Transaction in Own Shares Classification · 98% confidence The document is titled "AGGIORNAMENTO SUL PROGRAMMA DI ACQUISTO DI AZIONI PROPRIE" (Update on the Share Buyback Program) and details the number of own shares purchased by Philogen S.p.A. between July 18, 2022, and July 22, 2022, including daily transaction logs. This activity directly relates to the company managing its own capital structure by repurchasing shares. This aligns perfectly with the definition for 'Transaction in Own Shares' (Code: POS), which covers share repurchase/issuance. It is not a general financing update (CAP) as it is specifically about buybacks, nor is it a general regulatory filing (RNS) because a more specific category exists.
2022-07-25 Italian
Comunicato Stampa settimanale acquisto azioni proprie
Transaction in Own Shares Classification · 100% confidence The document title is "AGGIORNAMENTO SUL PROGRAMMA DI ACQUISTO DI AZIONI PROPRIE" (Update on the Share Buyback Program). The text details the number of own shares purchased during a specific period (July 11, 2022, to July 15, 2022), including daily transaction breakdowns and total consideration. This activity directly corresponds to the definition of a company reporting transactions involving its own shares, which maps to the 'Transaction in Own Shares' category. Filing Type Code: POS (Transaction in Own Shares).
2022-07-18 Italian
Comunicato Stampa settimanale acquisto azioni proprie
Transaction in Own Shares Classification · 100% confidence The document is titled "AGGIORNAMENTO SUL PROGRAMMA DI ACQUISTO DI AZIONI PROPRIE" (Update on the Share Buyback Program) and details the number of shares purchased by Philogen S.p.A. between July 4, 2022, and July 8, 2022. This explicitly describes a transaction where the company is buying back its own shares. This directly corresponds to the definition of 'Transaction in Own Shares' (Code: POS). The document is a formal announcement detailing the execution of a share repurchase program, not a general regulatory filing (RNS) or a report publication announcement (RPA), as it contains the substantive data itself.
2022-07-11 Italian
Allegato 3F - Giugno 2022
Director's Dealing Classification · 99% confidence The document is titled "SCHEMA DI COMUNICAZIONE DELLE OPERAZIONI SUI TITOLI DELL'EMITTENTE" (MODEL DISCLOSURE FOR TRANSACTIONS IN THE ISSUER'S SECURITIES). It details transactions (purchases/sales, indicated by 'A' for Acquisto/Buy in column 12) conducted by the issuer (PHILOGEN S.p.A.) in its own shares during June 2022. This structure and content directly correspond to reporting insider transactions or transactions in own shares by the company itself. Reviewing the definitions, 'Transaction in Own Shares' (Code: POS) is the most appropriate fit, as it covers the company buying back or selling its own shares. While 'Director's Dealing' (DIRS) covers insider trades, this document explicitly details transactions by the issuer itself, not just directors. The reference period is 06/2022, and the sending date is 06/07/2022. The document is a structured disclosure form, not a general announcement (RPA/RNS) or a full financial report.
2022-07-06 Italian

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.